OpenVSafe by OpenVAERS
Search V-safe

YCD-19853-83112

3 vaccinations 11 coded responses 33 check-ins 10 free-text entries 1 call case
Sex
Male
Age at first dose
31-35
ZIP prefix
206 / MD
Registered
2021-06-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-18
    Registered in v-safe
  2. 2021-06-18
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-18
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-06-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Swelling · None
    Adult check-in
  5. 2021-06-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Erythema — Feeling: Good
    Free text: Experiencing redness in left eye that is much heavier than normal.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Asthenopia, Eye haemorrhage, Ocular hyperaemia — Feeling: Good · Be unable to work or attend school
    Free text: Heavy reddening of the left eye. Looks like a broken blood vessel in the eye
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-06-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ocular hyperaemia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Redness of the left eye
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-06-22
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-06-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ocular hyperaemia — Feeling: Good
    Free text: Left eye redness still present but now finally beginning to lessen.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-06-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ocular hyperaemia — Feeling: Good
    Free text: Still have redness in left eye, but is now steadily decreasing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-06-25
    Survey response — day 7, dose 1
    MedDRA: Ocular hyperaemia — Feeling: Good
    Free text: Redness in left eye continuing to dissipate. But still monitoring.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-06-29
  13. 2021-06-29
    Call successful
    Completed over the phone
  14. 2021-07-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-07-09
    Dose 2 — Pfizer-BioNTech
  16. 2021-07-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-07-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-08-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-08-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-10-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-01-07
    Dose 3 — Pfizer-BioNTech
  24. 2022-01-07
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2022-01-07
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2022-01-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  27. 2022-01-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2022-01-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2022-01-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2022-01-12
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Congestion/Runny Nose and Coughing
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Have been diagnosed with COVID-19 despite being vaccinated.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-01-14
    Survey response — day 7, dose 3
    MedDRA: COVID-19, Cough, Respiratory tract congestion — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Have been diagnosed with COVID-19 as of 1/13/22. Have had coughing, congestion
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-21
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-01-28
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-02-04
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-02-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-02-18
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-04-08
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-07-08
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2023-01-07
    Survey response — 12 months, dose 3
    MedDRA: Inflammation, Ocular hyperaemia — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-06-18Pfizer-BioNTech
22021-07-09Pfizer-BioNTech No
32022-01-07Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-06-22 Successful
2021-06-29
Completed over the phone

Free text

Release 9 — day 0, dose 1

2021-06-18

Systemic reaction (other): No

Release 9 — days 1–6 daily, dose 1

2021-06-20

Systemic reaction (other): Experiencing redness in left eye that is much heavier than normal.

2021-06-21

Systemic reaction (other): Heavy reddening of the left eye. Looks like a broken blood vessel in the eye

2021-06-22

Systemic reaction (other): Redness of the left eye

2021-06-23

Systemic reaction (other): Left eye redness still present but now finally beginning to lessen.

2021-06-24

Systemic reaction (other): Still have redness in left eye, but is now steadily decreasing

Release 9 — day 7, dose 1

2021-06-25

Systemic reaction (other): Redness in left eye continuing to dissipate. But still monitoring.

Release 10 — days 1–6 daily, dose 3

2022-01-12

Systemic reaction (other): Congestion/Runny Nose and Coughing

2022-01-13

Systemic reaction (other): Have been diagnosed with COVID-19 despite being vaccinated.

Release 10 — day 7, dose 3

2022-01-14

Systemic reaction (other): Have been diagnosed with COVID-19 as of 1/13/22. Have had coughing, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDInflammation · · ✓
SDOcular hyperaemia · · ✓
SROAsthenopia ✓ ✓ ✓
SROCough · · ✓
SROCOVID-19 · · ✓
SROErythema ✓ ✓ ✓
SROEye haemorrhage ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROOcular hyperaemia ✓ ✓ ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release